High expression of HDAC9 correlates with poor patient prognosis.
Downregulation of HDAC9 inhibits cell proliferation in retinoblastoma cells.
Downregulation of HDAC9 induces cell cycle arrest at G1 phase in retinoblastoma cells.
Downregulation of HDAC9 suppresses tumor growth in nude mice.